Abstract Because of its competitive inhibitor activity against aminopeptidase B, bestatin isolated from the broth of Streptomyces olivoreticuli...
CureMatch Inc. is a San Diego-based company pioneering a digital precision medicine approach centered on the concept of personalized...
Perfusion cell culture, confined traditionally to the production of fragile molecules, is currently gaining broader attention in the...
Grey Wolf Therapeutics has raised £10 million to advance small molecules that help the immune system recognize tumors. The series A,...
Arcturus Therapeutics had a melodramatic 2018 - the San Diego biotech's CEO Joseph Payne was asked to leave for putting his interests...
Checkpoint inhibitors have done wonders for immuno-oncology, but the potent class of drugs doesn't work across all cancers. To remedy...
SAN DIEGO--Ligand Pharmaceuticals Incorporated announces closing an investment in Dianomi Therapeutics, Inc., a biopharmaceutical company...
Argenx gains access to ENHANZE® subcutaneous delivery technology for up to three targets, including exclusive rights to develop therapeutic...
Protein-based Cas9 in vivo gene editing therapeutics have practical limitations owing to their instability and low efficacy. To overcome...